Zai Lab LTD Schedule 13G passive stakes

TCG Crossover Fund II and III, led by Chen Yu, have collectively reported a 5.3% beneficial ownership stake in Zai Lab Limited.

RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. have filed a joint Schedule 13G, reporting beneficial ownership of 5.2% of Zai Lab Limited's ordinary shares.

RTW Investments, LP and Roderick Wong, M.D. have disclosed a 6.3% beneficial ownership stake in Zai Lab Limited as of December 31, 2025.

Qiming Corporate GP IV and affiliated entities disclose a 4.4% beneficial ownership in Zai Lab Limited as of December 31, 2025.

Wellington Management Group LLP and its affiliates reported a 4.3% beneficial ownership stake in Zai Lab Ltd. common stock as of December 31, 2025.

FMR LLC and Abigail P. Johnson disclose a 3.9% beneficial ownership stake in Zai Lab Ltd. common stock as of December 31, 2025.

RTW Investments and Roderick Wong filed an amended Schedule 13G, reporting a 2.1% beneficial ownership in Zai Lab Limited as of September 30, 2025.

Wellington Management Group LLP and its affiliates have reported a 6.03% beneficial ownership stake in ZAI LAB LTD. SB common stock as of September 30, 2025.

FMR LLC and Abigail P. Johnson have reported a beneficial ownership of 6.4% in ZAI LAB LTD, totaling 71,683,793 common shares as of September 30, 2025.

RTW Investments, LP and Roderick Wong, M.D. have disclosed a 5.1% beneficial ownership stake in Zai Lab Limited, totaling 55,368,760 ordinary shares.

Wellington Management Group and its affiliates have reduced their beneficial ownership in Zai Lab Ltd. to 4.5% of common stock, as disclosed in an Amendment No. 5 to their Schedule 13G filing.

Qiming Corporate GP IV, Ltd. and affiliated entities reported a 5.97% beneficial ownership stake in Zai Lab Limited as of June 30, 2025.

FMR LLC and Abigail P. Johnson have reported beneficial ownership of 8.5% of Zai Lab Ltd's common stock, totaling over 94 million shares.

Janus Henderson Group PLC has filed an amended Schedule 13G, reporting a 3.6% beneficial ownership stake in Zai Lab Ltd's common stock as of March 31, 2025.

Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G, disclosing a beneficial ownership of 6.4% in Zai Lab Ltd.'s common stock as of March 31, 2025.

Janus Henderson Group PLC has filed an amended Schedule 13G, revealing a beneficial ownership of 6.1% in Zai Lab Ltd's American Depositary Shares as of December 31, 2024.

FMR LLC and its affiliates, along with Abigail P. Johnson, have disclosed a beneficial ownership of 6.9% of ZAI LAB LTD's common stock as of December 31, 2024, held in the ordinary course of business.

Wellington Management Group LLP and its affiliated entities have filed an Amendment No. 3 to their Schedule 13G, disclosing a continued beneficial ownership of 9.2% in ZAI LAB LTD. common stock as of December 31, 2024.